HCC cell invasiveness was inhibited in vitro by VEGF modulation, which was mediated by the suppression of EphA3, suggesting potential as a prognostic marker and target for HCC treatment [87]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.